Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ipsen, a biopharmaceutical group engaged in the discovery and development of drugs for patient care, has appointed Marc de Garidel as chairman and CEO, effective from 22 November 2010.
Subscribe to our email newsletter
de Garidel started his career in 1983 with the Eli Lilly pharmaceutical Group where he held various roles, mainly finance related, firstly in France, then in the US and finally in Germany.
In 1995, he joined Amgen, the American biotech Group, as vice president, Finance and Treasury for Europe.
In 1998, he was appointed at Amgen’s headquarters in California as vice president, corporate controller and chief accounting officer.
In 2000, Garidel was offered the role of vice president, general manager for France, in charge of general management of Amgen France.
Garidel also served as president of the Biotech Committee of the French Pharmaceuticals Association (Leem, Les entreprises du medicament) from 2003 to 2006.